Monopar Therapeutics Inc

NASDAQ:MNPR  
5.92
-0.13 (-2.15%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Monopar Therapeutics Inc Stock, NASDAQ:MNPR

1000 Skokie Boulevard, Suite 350, Wilmette, Illinois 60091
United States of America
Phone: +1.847.388.0349
Number of Employees: 10

Description

Monopar Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. The firm engages in building a drug development pipeline through the licensing and acquisition of oncology therapeutics in late preclinical and clinical development stages. Its product pipeline includes Validive, Camsirubicin and MNPR-101. The company was founded by Chandler D. Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.